Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review

Moderate and severe plaque psoriasis: cost-of-illness study in Italy

(2016) Giorgio Colombo   Therapeutics and Clinical Risk Management

Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments

(2009) Annamaria Mazzotta et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome

(2009) R.J.B. Driessen et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy of Systemic Treatments for Moderate to Severe Plaque Psoriasis: Systematic Review and Meta-Analysis

(2009) Nick Bansback et al.   DERMATOLOGY

Quality of Life of Psoriasis Patients before and after Balneo - or Balneophototherapy

(2009) Stefano Tabolli et al.   YONSEI MEDICAL JOURNAL

Persistence with anti-tumor necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

(2009) Amr A Saad et al.   ARTHRITIS RESEARCH & THERAPY

Cardiovascular morbidity in psoriatic arthritis

(2008) D D Gladman et al.   ANNALS OF THE RHEUMATIC DISEASES

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

(2008) Marte Schrumpf Heiberg et al.   ARTHRITIS AND RHEUMATISM

Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome

(2008) R.J.B. Driessen et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

(2008) J. Schmitt et al.   BRITISH JOURNAL OF DERMATOLOGY

Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population

(2008) Eric Q. Wu et al.   CURRENT MEDICAL RESEARCH AND OPINION

Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany

(2008) M. Augustin et al.   DERMATOLOGY

Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis

(2008) Luigi Naldi et al.   DERMATOLOGY

National Registries of Systemic Treatment for Psoriasis and the European ‘Psonet’ Initiative

(2008) L.L.A. Lecluse et al.   DERMATOLOGY

The impact of psoriasis on health care costs and patient work loss

(2008) Joseph F. Fowler et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alefacept with methotrexate for treatment of psoriatic arthritis: Open-label extension of a randomized, double-blind, placebo-controlled study

(2008) Philip J. Mease et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry

(2008) A Nast et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

De testimonio: on the evidence for decisions about the use of therapeutic interventions

(2008) Michael Rawlins   LANCET